C Lagarde

1.7k total citations · 1 hit paper
44 papers, 1.3k citations indexed

About

C Lagarde is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, C Lagarde has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in C Lagarde's work include Lymphoma Diagnosis and Treatment (13 papers), Cancer Treatment and Pharmacology (10 papers) and Lung Cancer Treatments and Mutations (8 papers). C Lagarde is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Cancer Treatment and Pharmacology (10 papers) and Lung Cancer Treatments and Mutations (8 papers). C Lagarde collaborates with scholars based in France, United States and Netherlands. C Lagarde's co-authors include A. de Mascarel, F. Bonichon, M Trojani, N.B. Bui, Marc David, Jean‐Michel Coindre, J.‐F. Goussot, G Contesso, Jacques Rouëssé and M. Durand and has published in prestigious journals such as Oncogene, Antimicrobial Agents and Chemotherapy and International Journal of Cancer.

In The Last Decade

C Lagarde

41 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1984 974 citations M Trojani, F. Bonichon et al. International Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Lagarde France	10	948	648	340	308	274	44	1.3k
F. J. Pardo-Mindán Spain	14	601 0.6×	186 0.3×	199 0.6×	218 0.7×	196 0.7×	31	935
Jean-Jacques Michels France	12	573 0.6×	434 0.7×	294 0.9×	212 0.7×	191 0.7×	27	1.1k
K H Antman United States	15	651 0.7×	485 0.7×	151 0.4×	85 0.3×	147 0.5×	23	994
Young Chae Chu South Korea	17	673 0.7×	252 0.4×	258 0.8×	321 1.0×	141 0.5×	58	1.1k
Pack Gt United States	16	540 0.6×	454 0.7×	154 0.5×	309 1.0×	168 0.6×	51	1.1k
Katsuyuki Aozasa Japan	14	253 0.3×	558 0.9×	141 0.4×	161 0.5×	224 0.8×	33	1.1k
Jayashree Krishnan United States	19	215 0.2×	397 0.6×	137 0.4×	119 0.4×	458 1.7×	35	1.1k
Mikel San-Julián Spain	22	1.0k 1.1×	335 0.5×	144 0.4×	677 2.2×	83 0.3×	82	1.4k
Kimberly Moore Dalal United States	11	1.0k 1.1×	770 1.2×	244 0.7×	182 0.6×	163 0.6×	12	1.5k
Renata Langfort Poland	19	904 1.0×	594 0.9×	98 0.3×	109 0.4×	168 0.6×	145	1.6k

Countries citing papers authored by C Lagarde

Since Specialization

Citations

This map shows the geographic impact of C Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Lagarde more than expected).

Fields of papers citing papers by C Lagarde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Lagarde. The network helps show where C Lagarde may publish in the future.

Co-authorship network of co-authors of C Lagarde

This figure shows the co-authorship network connecting the top 25 collaborators of C Lagarde. A scholar is included among the top collaborators of C Lagarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Lagarde. C Lagarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lagarde, C, Bruce A. Bunnell, Elizabeth C. Martin, et al.. (2024). Obesity and leptin in breast cancer angiogenesis. Frontiers in Endocrinology. 15. 1465727–1465727. 3 indexed citations

Lagarde, C, Jorge A. Belgodere, Van T. Hoang, et al.. (2024). Obesity-associated epigenetic alterations and the obesity-breast cancer axis. Oncogene. 43(11). 763–775. 9 indexed citations

Melchers, Maria J., et al.. (2015). Plasma and Epithelial Lining Fluid Pharmacokinetics of Ceftolozane and Tazobactam Alone and in Combination in Mice. Antimicrobial Agents and Chemotherapy. 59(6). 3373–3376. 18 indexed citations

Ranger‐Rogez, Sylvie, et al.. (1995). [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].. PubMed. 24(17). 803–6. 6 indexed citations

Mauriac, L., M. Durand, J Chauvergne, et al.. (1988). Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre. Breast Cancer Research and Treatment. 11(2). 179–186. 16 indexed citations

Putten, Wim L.J. van, Vincent F. Guinee, R. Pfeiffer, et al.. (1988). Subsequent development of acute non‐lymphocytic leukemia in patients treated for Hodgkin's disease. International Journal of Cancer. 42(2). 252–255. 47 indexed citations

Lagarde, C, et al.. (1987). [Development of a knowledge-based system for aiding therapeutic decision in breast cancer].. PubMed. 74(3). 277–89.

Trojani, M, Houchingue Eghbali, M. Durand, et al.. (1983). Distinctive clinical features between lymphoblastic and immunoblastic non‐Hodgkin's malignant lymphomas (Kiel's classification) in a series of 141 patients. Hematological Oncology. 1(2). 159–163. 2 indexed citations

Bonichon, F., Marion Durand, B Hœrni, & C Lagarde. (1982). [Prognosis of lymphosarcomas. Multivariate analysis in a series of 334 patients].. PubMed. 69(2). 149–58. 1 indexed citations

10.

Brunet, R., et al.. (1982). Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.. PubMed. 66(7). 1563–5. 13 indexed citations

11.

Chauvergne, J, et al.. (1982). [Treatment of inflammatory breast cancer. Controlled study of a combination therapy program].. PubMed. 58(32). 1813–9. 1 indexed citations

12.

Richaud, Pierre, et al.. (1979). Total body irradiation (T.B.I.). Preliminary results of a new technique in 30 patients with hematologic malignancy.. PubMed. 155(11). 736–9. 5 indexed citations

13.

Durand, M., J Chauvergne, Pierre Richaud, et al.. (1978). Chimiothérapie d'induction des lymphomes malins non hodgkiniens. Résultats d'un essai contrôlé comparant deux quadruples associations.. Acta Haematologica. 59(2). 1 indexed citations

14.

Chauvergne, J, et al.. (1977). Induction chemotherapy of non-Hodgkin's malignant lymphomas. European Journal of Cancer (1965). 13(4-5). 399–400. 8 indexed citations

15.

Lagarde, C, et al.. (1976). Traitement des stades cliniques I et II de maladie de Hodgkin. Acta Haematologica. 55(5). 257–264. 3 indexed citations

16.

Lagarde, C, et al.. (1976). [Significance of chemotherapy complementary to radiotherapy in stages I and II in Hodgkin's disease].. PubMed. 62(1). 1–10. 5 indexed citations

17.

Hœrni, B, J Chauvergne, & C Lagarde. (1969). Métastase intrathyroidienne d'un épithélioma à cellules claires du rein.. 45(2). 1 indexed citations

18.

Lagarde, C, et al.. (1964). [EVALUATION OF 7 YEARS EXPERIENCE WITH ROTATORY ROENTGEN THERAPY OF CANCER OF THE ESOPHAGUS].. PubMed. 45. 732–5. 1 indexed citations

19.

Lagarde, C, et al.. (1964). [PALLIATIVE TREATMENT OF CANCERS WITH THIO-TEPA. STUDY OF 115 CASES. VALUE IN BREAST CANCERS].. PubMed. 72. 2285–90. 4 indexed citations

20.

Lagarde, C, et al.. (1957). [Idiopathic pulmonary hemosiderosis].. PubMed. 65(86). 1959–61. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact